Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38025
CAS Number:
118288-08-7
Lafutidine
Purity:
≥ 98 % (HPLC)
Synonym(s):
( Z )-2-[(furan-2-ylméthyl)sulfinyl]- N -[4-[[4-(pipéridin-1-ylméthyl)pyridin-2-yl]oxy]but-2-én-1-yl]acétamide, 2-[(2-furanylméthyl)sulfinyl]- N -[(2Z)-4-[[4-(1-pipéridinylméthyl)-2-pyridinyl]oxy]-2-butén-1-yl]-acétamide
Documents
$72.31 /25 mg
Taille
Request Bulk Quote
Informations sur le produit

Lafutidine is a potent compound recognized for its role as a gastroprotective agent, primarily utilized in the treatment of gastric ulcers and gastroesophageal reflux disease (GERD). This innovative drug works by enhancing mucosal defense mechanisms and promoting healing in the gastrointestinal tract, making it a valuable option for patients suffering from acid-related disorders. Its unique structure, featuring a furan moiety and a piperidine group, contributes to its effectiveness in reducing gastric acid secretion while simultaneously providing a protective effect on the gastric mucosa.

In clinical settings, Lafutidine has demonstrated significant efficacy in alleviating symptoms associated with peptic ulcers and has been shown to improve patient outcomes when used in combination with other therapeutic agents. Researchers and healthcare professionals appreciate its favorable safety profile and the potential for reduced side effects compared to traditional treatments. With its dual action of acid suppression and mucosal protection, Lafutidine stands out as a promising candidate for advancing gastrointestinal health and enhancing patient quality of life.

Numéro CAS 
118288-08-7
Formule moléculaire
C22H29N3O4S
Poids moléculaire 
431.55
Point de fusion 
97 - 101 °C
Informations générales
Numéro CAS 
118288-08-7
Formule moléculaire
C22H29N3O4S
Poids moléculaire 
431.55
Point de fusion 
97 - 101 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Lafutidine is widely utilized in research focused on:

  • Gastrointestinal Health: Lafutidine is primarily used in the treatment of gastric ulcers and gastroesophageal reflux disease (GERD). Its ability to enhance mucosal defense mechanisms makes it a preferred choice for patients looking for effective relief.
  • Pharmaceutical Development: In the pharmaceutical industry, Lafutidine serves as a model compound for developing new gastroprotective agents. Researchers study its mechanisms to create more effective treatments with fewer side effects.
  • Clinical Research: Clinical trials often investigate Lafutidine's efficacy and safety in various populations, providing valuable data that can lead to improved treatment protocols for gastrointestinal disorders.
  • Combination Therapies: Lafutidine is explored in combination with other medications to enhance therapeutic outcomes for patients with complex gastrointestinal issues, offering a tailored approach to treatment.
  • Patient Compliance: Its favorable side effect profile compared to traditional treatments encourages better patient adherence, making it a valuable option for long-term management of gastric conditions.

Citations